Extracorporeal blood photobiomodulation device
Patent Information
- Application Number
- TW114126175
- Authority / Receiving Office
- TW · TW
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-07-10
- Publication Date
- 2026-10-01
- Estimated Expiration
- 2045-07-09
Smart Images

Figure TWG2TB001913940_001 
Figure TWG2TB001913940_002 
Figure TWG2TB001913940_003
Abstract
Claims
1. An extracorporeal photodynamic blood activation device, comprising an input end and an output end respectively connected to a blood inlet conduit and a blood outlet conduit, the extracorporeal photodynamic blood activation device comprising: a T-shaped tube, which is a shell and forms a main channel and a branch channel extending from the middle portion of the main channel and fluidly communicating with the main channel, the two ends of the main channel being respectively connected to the input end and the output end; a light-emitting needle having a light guide connected to a light source, the light guide being inserted into the interior of the T-shaped tube from the branch channel and extending to a boundary between the branch channel and the main channel, a light-emitting surface of the light guide directly serving as the surface contour of the boundary, so that a fluid is confined within the main channel, and a light from the light source is transmitted into the main channel.
2. The extracorporeal photomodulated blood activation device as described in claim 1, wherein the main channel is perpendicular to the branch channel.
3. The extracorporeal photomodulated blood activation device as described in claim 1, wherein the main channel is a pen direct current channel, and the branch channel forms an angle with the main channel.
4. The extracorporeal photomodulated blood activation device as described in claim 1, wherein the light-emitting needle is a laser or an LED light tube.
5. The extracorporeal photomodulated blood activation device as described in claim 1, wherein the light guide is an optical fiber.
6. The extracorporeal photomodulated blood activation device as claimed in claim 1, wherein the number of light sources is multiple and the light sources have different wavelengths.
7. The extracorporeal photomodulated blood activation device as described in claim 6, wherein the light source is electrically connected to a control device for controlling the illumination time, activation sequence, and / or intensity of the light source.
8. The extracorporeal photomodulated blood activation device as claimed in claim 6, wherein the wavelength range of the light sources includes at least two light sources between 620~650nm, 650~700nm, 700~750nm, or / and 800~1200nm.
9. The extracorporeal photomodulated blood activation device as claimed in claim 1, wherein the light source comprises a laser light or an LED light source.
10. The extracorporeal photomodulated blood activation device as claimed in claim 1, wherein the cross-sectional profile of the light-emitting surface of the light guide tube conforms to the cross-sectional profile of the main channel at other locations outside the boundary between the branch channel and the main channel.
Citation Information
Patent Citations
Treat appearance with laser UVLED blood that hemodialysis system combined together
CN206473611U
Blood Chamber for an Optical Blood Monitoring System
US20120059234A1
